OUR SPONSORS
Since 1993, CMAX has partnered with local and international research organisations to deliver a range of end-to-end services for clinical trials. Many CMAX Sponsors are located internationally, including USA, China, Europe, South Korea, and Japan.
OUR ADVANTAGE
CMAX is recognised as one of Australia’s most experienced clinical trials service providers, delivering high quality, internationally-approved data which meets all regulatory requirements.
Since 1993, we have designed and delivered more than 800 early-phase clinical trials for clients across pharmaceutical, biotechnology and device companies.
Our modern, custom-built facility sits within one of the largest health and sciences clusters in the Southern Hemisphere, providing access to state-of-the-art facilities, equipment and world-class medical specialists.
OUR EXPERTISE
At CMAX, we operate across a wide range of therapeutic areas and have experience with most routes of study drug administration, working with a variety of investigational products including new chemical entities (NCEs), small molecules, monoclonal antibodies, vaccines, gene therapies and biosimilars.
Our purpose-built clinical trial unit is a fully-secure, self-contained facility equipped with ambulatory cardiac telemetry monitoring, on-site processing laboratories, a secure pharmacy room, and emergency call bells and procedures.
OUR STRENGTH
32+
Trusted Years
800+
Trials Completed
78
Bed Facility
Narsi Rangachari
COO and Co-Founder,
InCarda Therapeutics Inc.
SPONSOR TESTIMONIALS
“When we were searching for a Phase 1 clinic we quickly closed in on the city of Adelaide, Australia. The support of the ethics committee review and the R&D tax rebate reimbursement were a great support. We found that Adelaide offered us access to a number of experts, including CMAX.
It’s quite unique for government agencies like Health Industries South Australia to be so accessible but they were very ready to help smaller companies like InCarda who want to expand their R&D in Australia ”